Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 21-28

  Chan, Andrew T ^a,b,c   Giovannucci, Edward L ^b,c,d   Meyerhardt, Jeffrey A ^c,e   Schernhammer, Eva S ^b   Wu, Kana ^d   Fuchs, Charles S ^b,c,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CDC   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; DRUG USE; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; TABLET; TREATMENT DURATION;

EID: 37349041679     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.09.035     Document Type: Article

References (55)

1. Baron J.A., Cole B.F., Sandler R.S., et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348 (2003) 891-899
2. Sandler R.S., Halabi S., Baron J.A., et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348 (2003) 883-890
3. Benamouzig R., Deyra J., Martin A., et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125 (2003) 328-336
4. Cook N.R., Lee I.M., Gaziano J.M., et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 47-55
5. Gann P.H., Manson J.E., Glynn R.J., et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85 (1993) 1220-1224
6. Dube C., Rostom A., Lewin G., et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146 (2007) 365-375
7. Flossmann E., and Rothwell P.M. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369 (2007) 1603-1613
8. Giovannucci E., Rimm E.B., Stampfer M.J., et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121 (1994) 241-246
9. Rimm E., Giovannucci E., Stampfer M., et al. Reproducibility and validity of an expanded self-administered semiquantitative food questionnaire among health professionals. Am J Epidemiol 135 (1992) 1114-1126
10. Stampfer M.J., Willett W.C., Speizer F.E., et al. Test of the National Death Index. Am J Epidemiol 119 (1984) 837-839
11. Greene F., Page D., Fleming I., et al. AJCC Cancer Staging Handbook (2002), Springer-Verlag, New York
12. Chan A.T., Ogino S., and Fuchs C.S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356 (2007) 2131-2142
13. Chan A.T., Giovannucci E.L., Meyerhardt J.A., et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294 (2005) 914-923
14. Giovannucci E., Egan K.M., Hunter D.J., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 333 (1995) 609-614
15. Platz E.A., Willett W.C., Colditz G.A., et al. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 11 (2000) 579-588
16. Kavanagh A.M., Giovannucci E.L., Fuchs C.S., et al. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 9 (1998) 455-462
17. Wu K., Willett W.C., Fuchs C.S., et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94 (2002) 437-446
18. Fuchs C., Giovannucci E., Colditz G., et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331 (1994) 1669-1674
19. Patrono C., Garcia Rodriguez L.A., Landolfi R., et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
20. Eberhart C.E., Coffey R.J., Radhika A., et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
21. Kopp E., and Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265 (1994) 956-959
22. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
23. Chan T.A., Morin P.J., Vogelstein B., et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95 (1998) 681-686
24. He T.C., Chan T.A., Vogelstein B., et al. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99 (1999) 335-345
25. Yamamoto Y., Yin M.J., Lin K.M., et al. Sulindac inhibits activation of the NF-κB pathway. J Biol Chem 274 (1999) 27307-27314
26. Shureiqi I., Chen D., Lotan R., et al. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 60 (2000) 6846-6850
27. Steinbach G., Lynch P.M., Phillips R.K., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342 (2000) 1946-1952
28. Bertagnolli M.M., Eagle C.J., Zauber A.G., et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355 (2006) 873-884
29. Peleg I.I., Lubin M.F., Cotsonis G.A., et al. Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig Dis Sci 41 (1996) 1319-1326
30. Garcia Rodriguez L.A., and Huerta-Alvarez C. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal anti-inflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology 11 (2000) 376-381
31. Tangrea J.A., Albert P.S., Lanza E., et al. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 14 (2003) 403-411
32. Chan A.T., Giovannucci E.L., Schernhammer E.S., et al. A prospective study of aspirin use and the risk of colorectal adenoma. Ann Intern Med 140 (2004) 157-166
33. Chan A.T., Tranah G.J., Giovannucci E.L., et al. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst 97 (2005) 457-460
34. Sorensen H.T., Friis S., Norgard B., et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88 (2003) 1687-1692
35. Suh O., Mettlin C., and Petrelli N.J. Aspirin use, cancer, and polyps of the large bowel. Cancer 72 (1993) 1171-1177
36. Garcia-Rodriguez L.A., and Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs. Epidemiology 12 (2001) 88-93
37. Peleg I.I., Maibach H.T., Brown S.H., et al. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154 (1994) 394-399
38. Larsson S.C., Giovannucci E., and Wolk A. Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer 95 (2006) 1277-1279
39. Thun M.J., Namboodiri M.M., Calle E.E., et al. Aspirin use and risk of fatal cancer. Cancer Res 53 (1993) 1322-1327
40. Jacobs E.J., Thun M.J., Bain E.B., et al. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99 (2007) 608-615
41. Dimberg J., Samuelsson A., Hugander A., et al. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 45 (1999) 730-732
42. Kune G.A., Kune S., and Watson L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48 (1988) 4399-4404
43. Thun M., Calle E., Namboodiri M., et al. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325 (1991) 1593-1596
44. Rosenberg L., Palmer J.R., Zauber A.G., et al. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83 (1991) 355-358
45. Schreinemachers D.M., and Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5 (1994) 138-146
46. Muller A.D., Sonnenberg A., and Wasserman I.H. Diseases preceding colon cancer. A case-control study among veterans. Dig Dis Sci 39 (1994) 2480-2484
47. Muscat J.E., Stellman S.D., and Wynder E.L. Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer 74 (1994) 1847-1854
48. Reeves M.J., Newcomb P.A., Trentham-Dietz A., et al. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 5 (1996) 955-960
49. La Vecchia C., Negri E., Franceschi S., et al. Aspirin and colorectal cancer. Br J Cancer 76 (1997) 675-677
50. Rosenberg L., Louik C., and Shapiro S. Nonsteroidal anti-inflammatory drug use and reduced risk of large bowel carcinoma. Cancer 82 (1998) 2326-2333
51. Collet J.P., Sharpe C., Belzile E., et al. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 81 (1999) 62-68
52. Langman M.J., Cheng K.K., Gilman E.A., et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 320 (2000) 1642-1646
53. Coogan P.F., Rosenberg L., Louik C., et al. NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes Control 11 (2000) 249-255
54. Mahipal A., Anderson K.E., Limburg P.J., et al. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 15 (2006) 1785-1790
55. U.S. Preventive Services Task Force recommendation statement. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. Ann Intern Med 146 (2007) 361-364